| 1 |
34624096 |
10.1182/blood.2020010405 |
2022 |
ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells. |
MEF2C |
| 2 |
33150819 |
10.1080/08880018.2020.1838013 |
2021 |
<i>KMT2A</i>-rearranged diffuse large B-cell lymphoma in a child: a case report and molecular characterization. |
MEF2C |
| 3 |
34440292 |
10.3390/genes12081118 |
2021 |
T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness. |
MEF2C |
| 4 |
31900516 |
10.1007/s00210-019-01764-6 |
2020 |
A novel MEF2C mutation in lymphoid neoplasm diffuse large B-cell lymphoma promotes tumorigenesis by increasing c-JUN expression. |
MEF2C |
| 5 |
32142900 |
10.1016/j.jmoldx.2020.02.004 |
2020 |
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia. |
MEF2C |
| 6 |
32913188 |
10.1038/s41419-020-02949-1 |
2020 |
A small molecular compound CC1007 induces cross-lineage differentiation by inhibiting HDAC7 expression and HDAC7/MEF2C interaction in BCR-ABL1<sup>-</sup> pre-B-ALL. |
MEF2C |
| 7 |
33094287 |
10.1093/narcan/zcaa029 |
2020 |
Activation-induced cytidine deaminase localizes to G-quadruplex motifs at mutation hotspots in lymphoma. |
MEF2C |
| 8 |
33298918 |
10.1038/s41467-020-20136-w |
2020 |
Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors. |
MEF2C |
| 9 |
30171027 |
10.3324/haematol.2017.186320 |
2019 |
Clinical and molecular characteristics of <i>MEF2D</i> fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in <i>MEF2D-HNRNPH1</i> gene fusion. |
MEF2C |
| 10 |
30190342 |
10.3324/haematol.2018.196055 |
2019 |
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. |
MEF2C |
| 11 |
29279377 |
10.1073/pnas.1717125115 |
2018 |
Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia. |
MEF2C |
| 12 |
28482719 |
10.1080/10428194.2017.1312383 |
2017 |
MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy. |
MEF2C |
| 13 |
26957223 |
10.1038/mt.2016.55 |
2016 |
Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes. |
MEF2C |
| 14 |
27322685 |
10.18632/oncotarget.9982 |
2016 |
Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia. |
MEF2C |
| 15 |
25675295 |
10.1038/cddis.2014.594 |
2015 |
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma. |
MEF2C |
| 16 |
25716962 |
|
2015 |
Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling. |
MEF2C |
| 17 |
26172269 |
10.1371/journal.pone.0132926 |
2015 |
BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression? |
MEF2C |
| 18 |
26245647 |
10.1038/ncomms8953 |
2015 |
MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation. |
MEF2C |
| 19 |
26473286 |
10.18632/oncotarget.5556 |
2015 |
Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma. |
MEF2C |
| 20 |
26670384 |
10.1128/mBio.01863-15 |
2015 |
Common Viral Integration Sites Identified in Avian Leukosis Virus-Induced B-Cell Lymphomas. |
MEF2C |
| 21 |
23975177 |
10.3324/haematol.2013.090233 |
2014 |
Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors. |
MEF2C |
| 22 |
24304814 |
10.1038/jid.2013.461 |
2014 |
miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma. |
MEF2C |
| 23 |
22997707 |
10.1134/s1068162012030089 |
2012 |
[The functional analysis of polymorphic insertions of Alu retroelements at acute lymphoblastic leukemia]. |
MEF2C |
| 24 |
21261500 |
10.3109/10428194.2010.537003 |
2011 |
Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia. |
MEF2C |
| 25 |
21425961 |
10.3109/10428194.2011.566391 |
2011 |
Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia. |
MEF2C |
| 26 |
21481790 |
10.1016/j.ccr.2011.02.008 |
2011 |
Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. |
MEF2C |
| 27 |
19056693 |
10.1182/blood-2007-09-113597 |
2009 |
HOXA9 is required for survival in human MLL-rearranged acute leukemias. |
MEF2C |
| 28 |
18079734 |
10.1038/sj.leu.2405067 |
2008 |
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. |
MEF2C |
| 29 |
16455055 |
10.1016/j.bbrc.2006.01.036 |
2006 |
Evidence for the interaction of the regulatory protein Ki-1/57 with p53 and its interacting proteins. |
MEF2C |
Datasets
Models
